In the 15 years since Stuart Grant and Jay Eisenhofer started their own law firm, Grant & Eisenhofer has grown from four attorneys to almost 75 in three offices. But the firm never lost focus on its goal, Grant said to serve the needs of institutional investors. “We had seen at the time that the corporate defense bar was well represented,” he said. “Institutional investors had a lot of money invested and yet nobody was representing them.”
During the past year the Wilmington, Del.-based firm represented the lead whistleblower in the government’s False Claims Act case against Abbott Laboratories. That $1.6 billion settlement, announced in May, involved alleged illegal marketing of the anti-seizure drug Depakote to children and geriatric patients.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
